跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68,268 条关于
“parainfluenza virus Type 3”
全部
68,268
临床试验
43,951
药物
6,198
机构
1,397
资讯
16,722
11个月前
Clover Biopharmaceuticals Reports Positive Phase I Data for First-in-Class RSV-hMPV-PIV3 Combination Vaccines
3年前
Clover Biopharmaceuticals Advances RSV Vaccine SCB-1019 with U.S. IND Clearance for Revaccination Study
去年
Sanofi Acquires Vicebio for $1.15 Billion to Expand Respiratory Vaccine Pipeline with Molecular Clamp Technology
去年
Clover Advances RSV Vaccine Program with FDA Clearance for Revaccination Trial
2年前
RSV Vaccine Development Surges with New Approvals and Diverse Strategies
去年
Blue Lake and CyanVac Report Promising Phase 1 Results for Intranasal COVID-19 Vaccine CVXGA
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
11年前
Modified Herpes Virus Shows Promise in Phase 3 Melanoma Trial, Improving Survival by 20 Months
8天前
FDA approves oncolytic virus
去年
Phase 3 Trial Demonstrates Selumetinib Efficacy in Adults with Neurofibromatosis Type 1
第 1 页，共 1673 页
上一页
下一页
